Thursday, April 23, 2026 | 11:44 PM ISTहिंदी में पढें
Bafna Pharmaceuticals Ltd
Non-Applicability Of Declaration Of In Terms Of Regulation 32 Of SEBI (LODR) Regulations 2015.
12:26 PM, 13th Jul 2023
the Statement of Deviation and Variation of proceeds of Public Issue Right Issue Preferential Issue Qualified Institutional Placement etc. required to be submitted in terms of Regulation 32 of SEBI (LODR) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24 2019 is not applicable to Bafna Pharmaceuticals Limited (the Company) for the quarter ended June 30 2023.